289 related articles for article (PubMed ID: 26084216)
1. Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus.
Grzeda E; Schlicker E; Luczaj W; Harasim E; Baranowska-Kuczko M; Malinowska B
J Physiol Pharmacol; 2015 Jun; 66(3):343-53. PubMed ID: 26084216
[TBL] [Abstract][Full Text] [Related]
2. CB
Grzęda E; Schlicker E; Toczek M; Zalewska I; Baranowska-Kuczko M; Malinowska B
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):25-35. PubMed ID: 27659492
[TBL] [Abstract][Full Text] [Related]
3. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
Chiba T; Ueno S; Obara Y; Nakahata N
J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats.
Wheal AJ; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 2007 Nov; 152(5):717-24. PubMed ID: 17700721
[TBL] [Abstract][Full Text] [Related]
5. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.
Malinowska B; Kwolek G; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):562-9. PubMed ID: 11770012
[TBL] [Abstract][Full Text] [Related]
6. Cross-Talk between CB
Mińczuk K; Schlicker E; Malinowska B
Cells; 2022 May; 11(9):. PubMed ID: 35563848
[TBL] [Abstract][Full Text] [Related]
7. Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats.
Kwolek G; Zakrzeska A; Schlicker E; Göthert M; Godlewski G; Malinowska B
Br J Pharmacol; 2005 Jul; 145(5):567-75. PubMed ID: 15834445
[TBL] [Abstract][Full Text] [Related]
8. Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.
Ho WS; Gardiner SM
Br J Pharmacol; 2009 Jan; 156(1):94-104. PubMed ID: 19133994
[TBL] [Abstract][Full Text] [Related]
9. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats.
del Carmen García M; Adler-Graschinsky E; Celuch SM
Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):270-6. PubMed ID: 14504685
[TBL] [Abstract][Full Text] [Related]
10. Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.
Shimizu T; Tanaka K; Shimizu S; Higashi Y; Yawata T; Nakamura K; Taniuchi K; Ueba T; Yuri K; Saito M
Neuropharmacology; 2015 Aug; 95():278-89. PubMed ID: 25882827
[TBL] [Abstract][Full Text] [Related]
11. CB1 receptors in the paraventricular nucleus of the hypothalamus modulate the release of 5-HT and GABA to stimulate food intake in rats.
Cruz-Martínez AM; Tejas-Juárez JG; Mancilla-Díaz JM; Florán-Garduño B; López-Alonso VE; Escartín-Pérez RE
Eur Neuropsychopharmacol; 2018 Nov; 28(11):1247-1259. PubMed ID: 30217553
[TBL] [Abstract][Full Text] [Related]
12. Differential mechanisms mediating depressor and diuretic effects of anandamide.
Li J; Wang DH
J Hypertens; 2006 Nov; 24(11):2271-6. PubMed ID: 17053550
[TBL] [Abstract][Full Text] [Related]
13. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion.
da Veiga MA; Fonseca Bloise F; Costa-E-Sousa RH; Souza LL; Almeida NA; Oliveira KJ; Pazos-Moura CC
J Endocrinol; 2008 Nov; 199(2):235-42. PubMed ID: 18755884
[TBL] [Abstract][Full Text] [Related]
15. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.
Wagner JA; Abesser M; Harvey-White J; Ertl G
J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503
[TBL] [Abstract][Full Text] [Related]
16. Anandamide transporter-mediated regulation of the micturition reflex in urethane-anesthetized rats.
Honda M; Yoshimura N; Kawamoto B; Hikita K; Muraoka K; Shimizu S; Saito M; Chancellor MB; Takenaka A
Int Urol Nephrol; 2016 Sep; 48(9):1407-12. PubMed ID: 27256398
[TBL] [Abstract][Full Text] [Related]
17. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
Béquet F; Uzabiaga F; Desbazeille M; Ludwiczak P; Maftouh M; Picard C; Scatton B; Le Fur G
Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
Shivachar AC
Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
[TBL] [Abstract][Full Text] [Related]
19. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide.
Varga K; Lake K; Martin BR; Kunos G
Eur J Pharmacol; 1995 May; 278(3):279-83. PubMed ID: 7589169
[TBL] [Abstract][Full Text] [Related]
20. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
